Zhongnan Medical Journal Press

Home Results

A total of 6 result was found. Results that relate to LI Peng

Analysis of the characteristics and risk factors of levofloxacin-induced arrhythmias

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):37-44.
11047 times 2345 times

GUO Haili GUO Daihong ZHU Man LI Peng FU An LI Chao LU Jingchuan

Levofloxacin Arrhythmia Risk factors Automatic monitoring Propensity score matching
Details
Analysis of 2 642 reports of adverse reactions related to carbapenems and risk signal mining

Published on Chinese Journal of Pharmacoepidemiology 2024,33(3):251-258.
9634 times 2503 times

LI Haiyan GUO Daihong YUAN Yonghua ZHU Man GAO Ao LU Jingchuan FU An LI Chao LI Peng ZHAO Anqi

Carbapenems Antibacterial drugs Adverse drug reactions Data mining Retrospective analysis
Details
Evaluation of the efficacy of Huoxue Tongluo recipe iontophoresis combined with butyphthalide sequential therapy in hemiplegia patients with cerebral ischemic stroke

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):788-795.
8565 times 1931 times

ZHANG Hongli LI Peng HU Jie [LV

Traditional Chinese medicine iontophoresis Butyphthalide sequential therapy Cerebral ischemic stroke Hemiplegia Clinical efficacy Safety
Details
Establishment, optimization and practice of an automatic central nervous system adverse reactions monitoring module based on hospital information system data

Published on Chinese Journal of Pharmacoepidemiology 2024,33(9):971-977.
12852 times 2197 times

LI Haiyan GUO Daihong ZHU Man GAO Ao LU Jingchuan FU An LI Chao LI Peng ZHAO Anqi

Central nervous system Adverse drug reaction Imipenem/cilastatin Text classification technology Real world study
Details
Microbial community analysis of clean workshops after ozone disinfection in three pharmaceutical companies

Published on Frontiers in Pharmaceutical Sciences 2025,29(4):588-594.
7939 times 1550 times

QU Lu CHENG Hongjie CHEN Chaojie LI Peng ZHAO Xinxia

Ozone disinfection Clean workshop Microbial community Matrix-assisted laser desorption ionization time-of-flight mass spectrometry VITEK® 2 Compact
Details
Interpretation of the Guiding Principles of Good AI Practice in Drug Development jointly released by FDA and EMA

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):885-894.
1558 times 555 times

ZHANG Hua LI Pengfei FU Hongjun

U.S. Food and Drug Administration European Medicines Agency Ar-tificial intelligence Drug development Guide principles Regulatory science
Details